In line with the previous report, this finding highlights aberrant activation of SREBP-1/SCAP axis to amplify cancer stem cells that are lacking differentiation and depend on lipogenesis, as this axis is also the master regulator of lipid metabolism [32,33]. This evidence concerns the gene SREBF1 and cancer.